Jenburkt Pharma - Quaterly Results

26 Oct 2021 Evaluate
The revenue zoomed 16.48% to Rs. 355.08 millions for the quarter ended September 2021 as compared to Rs. 304.85 millions during the corresponding quarter last year.An average growth of 40.54% was recorded for the quarter ended September 2021 to Rs. 79.70  millions from Rs. 56.71 millions.Operating profit for the quarter ended September 2021 rose to 114.59 millions as compared to 81.93 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 355.08 304.85 16.48 626.88 479.16 30.83 1092.94 1188.91 -8.07
Other Income 11.91 10.23 16.42 23.86 19.99 19.36 43.08 42.18 2.13
PBIDT 114.59 81.93 39.86 180.14 97.96 83.89 241.52 239.63 0.79
Interest 1.09 1.24 -12.10 2.12 2.36 -10.17 4.74 5.26 -9.89
PBDT 113.50 80.69 40.66 178.02 95.60 86.21 236.78 234.37 1.03
Depreciation 4.54 5.06 -10.28 8.88 10.00 -11.20 20.35 22.99 -11.48
PBT 108.96 75.63 44.07 169.14 85.60 97.59 216.43 211.38 2.39
TAX 29.26 18.92 54.65 42.93 18.81 128.23 51.39 62.68 -18.01
Deferred Tax -0.74 -1.08 -31.48 -1.35 -5.04 -73.21 -3.91 3.69 -205.96
PAT 79.70 56.71 40.54 126.21 66.79 88.97 165.04 148.70 10.99
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 32.27 26.88 20.08 28.74 20.44 40.56 22.10 20.16 9.64

Jenburkt Pharma Share Price

1074.70 -14.25 (-1.31%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×